Plasma therapy not beneficial in reducing mortality, progression to severe Covid-19: ICMR Study

The 'open-label parallel-arm phase II multicentre randomized controlled trial' (PLACID Trial) was conducted across 39 public and private hospitals across India between April 22 and July 14 to find effectiveness of convalescent plasma (CP) for the treatment of Covid-19, it said.